1. Canadian product monograph for Plaquenil updated

   News item 03 February 2024 Pages: 1 - 1

2. Haleon recalls Robitussin Honey CF Max cough syrups

   News item 03 February 2024 Pages: 2 - 2

3. Imatinib-related thrombotic microangiopathy

   News item 03 February 2024 Pages: 3 - 3

4. Insufficient evidence to link Long COVID to COVID-19 vaccines

   News item 03 February 2024 Pages: 4 - 4

5. ISMP publishes 2024 high-alert medication list

   News item 03 February 2024 Pages: 5 - 5

6. Measures to reduce serious pseudoephedrine-related AEs

   News item 03 February 2024 Pages: 6 - 6

7. Omega-3 acid ethyl esters-related atrial fibrillation

   News item 03 February 2024 Pages: 7 - 7

8. Rivastigmine-related QT prolongation and torsades de pointes

   News item 03 February 2024 Pages: 8 - 8

9. Sunitinib: risk of retinal detachment

   News item 03 February 2024 Pages: 9 - 9

10. GLP-1RA: no increased risk of pancreatic cancer

    Clinical study 03 February 2024 Pages: 10 - 10

11. Haloperidol- and quetiapine-induced severe QT prolongation

    Clinical study 03 February 2024 Pages: 11 - 11

12. In utero exposure to COVID-19 vaccines has no neurodevelopmental impact

    Clinical study 03 February 2024 Pages: 12 - 12

13. Other adverse reaction research

    News item 03 February 2024 Pages: 13 - 13

14. Abiraterone/degarelix/enzalutamide

    Case report 03 February 2024 Pages: 14 - 14

15. Acetazolamide/Furosemide/Topiramate

    Case report 03 February 2024 Pages: 15 - 15

16. Adalimumab

    Case report 03 February 2024 Pages: 16 - 16

17. Adalimumab/Amoxicillin/clavulanic-acid

    Case report 03 February 2024 Pages: 17 - 17

18. Adalimumab/BBIBP-CorV

    Case report 03 February 2024 Pages: 18 - 18

19. Alteplase/aspirin/hydrogen-peroxide

    Case report 03 February 2024 Pages: 19 - 19

20. Aminolevulinic-acid/Terbinafine

    Case report 03 February 2024 Pages: 20 - 20

21. Amiodarone/Metoprolol

    Case report 03 February 2024 Pages: 21 - 21

22. Amiodarone/Mexiletine/Sotalol

    Case report 03 February 2024 Pages: 22 - 22

23. Amoxicillin

    Case report 03 February 2024 Pages: 23 - 23

24. Anaesthetics/Furosemide

    Case report 03 February 2024 Pages: 24 - 24

25. Antibacterials/Prednisone/Sotrovimab

    Case report 03 February 2024 Pages: 25 - 25

26. Antiepileptic-drugs

    Case report 03 February 2024 Pages: 26 - 26

27. Antihyperlipidaemics

    Case report 03 February 2024 Pages: 27 - 27

28. Antineoplastics

    Case report 03 February 2024 Pages: 28 - 28

29. Antineoplastics

    Case report 03 February 2024 Pages: 29 - 29

30. Antineoplastics

    Case report 03 February 2024 Pages: 30 - 30

31. Antineoplastics

    Case report 03 February 2024 Pages: 31 - 31

32. Apixaban/factor-VIII-inhibitor-bypassing-fraction/rivaroxaban

    Case report 03 February 2024 Pages: 32 - 32

33. Apixaban/Tozinameran

    Case report 03 February 2024 Pages: 33 - 33

34. Azathioprine/ciclosporin/infliximab

    Case report 03 February 2024 Pages: 34 - 34

35. Benralizumab/Dupilumab/Levocetirizine

    Case report 03 February 2024 Pages: 35 - 35

36. Benzylpenicillin

    Case report 03 February 2024 Pages: 36 - 36

37. Bimatoprost/Dorzolamide/timolol

    Case report 03 February 2024 Pages: 37 - 37

38. Binimetinib/encorafenib

    Case report 03 February 2024 Pages: 38 - 38

39. Bisoprolol/perindopril/nebivolol

    Case report 03 February 2024 Pages: 39 - 39

40. Brexpiprazole

    Case report 03 February 2024 Pages: 40 - 40

41. Cabozantinib/ipilimumab/nivolumab

    Case report 03 February 2024 Pages: 41 - 41

42. Calcitriol/calcium-carbonate

    Case report 03 February 2024 Pages: 42 - 42

43. Calcium

    Case report 03 February 2024 Pages: 43 - 43

44. Capecitabine/Oxaliplatin

    Case report 03 February 2024 Pages: 44 - 44

45. Cefepime

    Case report 03 February 2024 Pages: 45 - 45

46. Cefotaxime

    Case report 03 February 2024 Pages: 46 - 46

47. Cenobamate/levetiracetam/phenobarbital

    Case report 03 February 2024 Pages: 47 - 47

48. Chlorpromazine

    Case report 03 February 2024 Pages: 48 - 48

49. Ciclesonide/mometasone/sodium-citrate

    Case report 03 February 2024 Pages: 49 - 49

50. Cisplatin/Gemcitabine/Pembrolizumab

    Case report 03 February 2024 Pages: 50 - 50